1. Home
  2. CBFV vs CRBU Comparison

CBFV vs CRBU Comparison

Compare CBFV & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CB Financial Services Inc.

CBFV

CB Financial Services Inc.

HOLD

Current Price

$36.23

Market Cap

174.1M

Sector

Finance

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.38

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBFV
CRBU
Founded
1901
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.1M
192.4M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CBFV
CRBU
Price
$36.23
$2.38
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$38.00
$10.75
AVG Volume (30 Days)
1.8K
1.6M
Earning Date
04-22-2026
05-08-2026
Dividend Yield
3.12%
N/A
EPS Growth
N/A
3.64
EPS
0.73
N/A
Revenue
$43,557,000.00
N/A
Revenue This Year
$48.93
$1.63
Revenue Next Year
$7.97
$10.93
P/E Ratio
$48.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.11
$0.96
52 Week High
$37.75
$3.53

Technical Indicators

Market Signals
Indicator
CBFV
CRBU
Relative Strength Index (RSI) 59.26 67.29
Support Level $34.08 $1.75
Resistance Level $36.44 $2.97
Average True Range (ATR) 0.55 0.17
MACD 0.12 0.03
Stochastic Oscillator 100.00 90.48

Price Performance

Historical Comparison
CBFV
CRBU

About CBFV CB Financial Services Inc.

CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: